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Abstract Over the last two decades the molecular and
cellular mechanisms underlying T cell activation, expan-
sion, differentiation, and memory formation have been
intensively investigated. These studies revealed that the
generation of memory T cells is critically impacted by a
number of factors, including the magnitude of the inflam-
matory response and cytokine production, the type of
dendritic cell [DC] that presents the pathogen derived
antigen, their maturation status, and the concomitant pro-
vision of costimulation. Nevertheless, the primary stimulus
leading to T cell activation is generated through the T cell
receptor [TCR] following its engagement with a peptide
MHC ligand [pMHC]. The purpose of this review is to
highlight classical and recent findings on how antigen
recognition, the degree of TCR stimulation, and intracel-
lular signal transduction pathways impact the formation of
effector and memory T cells.
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Introduction
Prior to an infection, naı¨ve mice contain very low
numbers of T cells specific to any foreign antigen. Though
there is some variation, the frequency of such cells within
the total CD8 or CD4 population has been estimated to be
about 1 in 100,000 cells and this seems to hold true for
both murine and human T cells [1–6]. After a viral or
bacterial infection those rare antigen-specific T cells
become activated and follow very typical response pat-
terns. These consist of an expansion phase which lasts
about 7–8 days in mice [7, 8] and about 14 days in human
[9]. In this phase, antigen-specific T cells massively
expand, and a single naı¨ve T cell can undergo more than
15 consecutive divisions, and over time, one cell can
generate more than 50,000 descendants [2]. Concomitant
with their expansion, T cells differentiate into effector
cells. The expansion phase is followed by a contraction
phase during which the majority of antigen-specific T
cells undergo apoptotic cell death, although a fraction of
the antigen-specific T cells move on and differentiate into
memory T cells.
How long does a T cell need to be stimulated
by antigen?
In secondary lymphoid organs, naı¨ve or memory T cells
screen the pMHC complexes that are presented by DC. In
the absence of infection, DC present only self-peptide
MHC complexes, and the TCRs on the vast majority of T
cells will very weakly interact with these complexes. Live
cell in vivo imaging studies revealed that in this situation
the DC T cell contacts are very brief, and the T cells are
highly motile and quickly move from one DC to another
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[10, 11]. In contrast, when a DC presents a foreign-peptide
MHC complex, then those T cells expressing a TCR which
has a sufficient affinity for foreign pMHC (see below for
details) become selectively less motile and interact for
longer periods of time with the DC [11] compared to other
T cells which lack specificity for the foreign pMHC.
During these longer periods of interaction, the T cells are
thought to be instructed to undergo proliferation and
differentiation.
An important question has been how long a T cell
needs to interact with a foreign antigen-presenting DC
and, more precisely, how long it needs to be stimulated by
the antigen in order undergo differentiation into effector
and memory T cells. In vitro experiments, where cells
were first exposed for a defined amount of time to antigen
and then separated from the antigenic stimulus, showed
that approximately 2 h of antigen exposure is sufficient to
activate T cells and that the cells subsequently divide and
differentiate in the absence of antigen. This observation
led to the concept that a short duration of antigen expo-
sure leads to the activation of a differentiation program
that even in the absence of further antigen exposure
controls T cell differentiation [12, 13]. Using the same
in vitro T cell activation system, but combined with a
subsequent in vivo transfer of the cells, showed that
programmed T cell expansion can also occur in vivo.
However, in this setup, the cells needed to be stimulated for
4–20 h and thus somewhat longer compared to continuous
in vitro conditions [14].
Nevertheless, the question remained how far the pro-
grammed expansion concept is applicable to T cell
differentiation occurring entirely in vivo and during a real
infection where antigen presentation can persist for long
periods of time [15, 16]. In vivo imaging studies using
peptide-loaded DC and transgenic T cells indicate that T
cell DC interactions last about 12–24 h. Afterwards, T cells
dissociate from the APC and begin to proliferate [10, 17].
This behavior is well in line with the concept of pro-
grammed T cell differentiation. However, in order to
formally prove that T cell programming occurs in vivo, it
required a system where antigen presentation can be ter-
minated at any given time. An approach for controlling
antigen presentation in vivo is to induce T cell activation
through antigen-loaded dendritic cells that transgenically
express a high affinity diphtheria toxin receptor. Since mice
normally lack this receptor, diphtheria toxin injection can
be used to selectively deplete antigen-presenting DC.
Using this system, it was interestingly observed that longer
periods of presentation do not alter the differentiation of T
cells but impact the numbers of effector and memory T
cells that arise after the stimulation [18]. While these
observations go along with the idea of programmed
expansion, they also reveal that the clonal burst size is not a
programmed event and that it is dependent on further
antigen recognition during the T cell expansion phase.
Similar observations were subsequently made in a number
of systems: ablating DC at later time points during an
influenza infection [19], injecting Listeria monocytogenes-
infected mice at day 3 with an antibody that blocks pMHC
recognition by T cells [20], and experimental reduction of
virus burden at defined time points post-infection [21].
Moreover, when naı¨ve T cells are activated in vitro and
then transferred into acutely infected hosts that either
present a cognate antigen for these T cells or not, then T
cells show much stronger expansion in the presence of
antigen [22]. Taken together, shortening antigen presenta-
tion seems to have little to no impact on the functional
differentiation of effector and memory T cells, suggesting
that the sole differentiation of T cells is indeed driven by a
differentiation program initiated at very early time points
during an infection. Nevertheless, optimum T cell expan-
sion seems to require persistence of antigen through the T
cell expansion phase.
What remains ill defined is which types of antigen-
presenting cell (APC) promote or impact the clonal burst
size of the T cell population. Is this a function of the same
type of DC that initiates T cell priming or does it involve
other types of DC or even non-professional APC? Inves-
tigating T cell migration kinetics in the spleen in response
to bacterial infection revealed that, after an initial wave of
proliferation, some T cells can again be found clustered
with DC [20]; this DC–T cell re-association might boost
the T cell responses. T cell expansion can also be boosted
upon peripheral antigen exposure, and here tissue-resident
DC and other types of APC might be involved. In the
lungs, it has been shown that resident DC enhance T cell
effector function [23], but this could be due to enhanced T
cell expansion [24].
Interestingly, CD4 T cells appear to significantly differ
from CD8 T cells when it comes to their activation and
differentiation requirements. It has been shown that longer
periods of antigen presentation are needed to activate CD4
T cells and that shortening antigen presentation interferes
with T cell differentiation and T cell trafficking to
peripheral tissues [25, 26]. Moreover, while adoptive
transfer of TCR transgenic CD8 T cells increases the pre-
cursor frequency, this does not prevent the generation of
memory T cells during an infection [27]. On the other
hand, the same procedure performed with CD4 transgenic
T cells strongly impacts T cell differentiation and pre-
vented the formation of memory [28]. Similar results were
obtained when injecting low doses of antibodies that block
pMHC and TCR interaction [29]. In addition, the genera-
tion of CD8 effector T cells seems inevitably linked to the
subsequent emergence of memory T cells. In contrast, with
CD4 T cells, it has been observed that the generation of
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functional effector T cells during an infection sometimes
does not lead to the generation of T cell memory [25, 26].
These observations highlight clear differences between
CD4 and CD8 T cells in terms of programmed effector and
memory T cell differentiation.
Impact of the strength (quality) of the stimulus:
Flexibility of T cells to respond to different qualities
of pMHC
T cells are equipped with an antigen receptor and a sig-
naling apparatus that show an astonishing flexibility and
precision when recognizing pMHC ligands. The ability of
T cells to respond to pMHC that differ greatly in their
strength of interaction with the TCR is best illustrated by
the processes that take place during positive and negative
selection in the thymus. Insight into thymic selection pro-
cesses can be obtained by performing so called fetal thymic
organ cultures (see Fetal thymic organ culture (FTOC)).
Here, thymi harvested from TCR transgenic mice are cul-
tured in the presence of different peptide ligands which are
examined for their impact on T cell development. As
explained in Fetal thymic organ culture (FTOC) and
Altered peptide ligands (APL) these cultures are normally
performed either with the natural ‘‘agonist’’ peptide cor-
responding to the transgenic T cells or with so called
altered peptide ligands (APL) which are variants of the
original peptide but which provide a lower level of stim-
ulation to the transgenic T cells (see Altered peptide
ligands (APL)). Using this method, it turned out that
ligands which bind to the OT-1 TCR with a physical
strength (see Defining the TCR binding and stimulatory
potency of peptide MHC complexes) of 20–60 lM (R4,
E1, or G4 APL) support positive selection while tenfold
higher affinities (i.e. wild-type N4 ligand) have been shown
to lead to negative selection in the thymus [30]. While a
tenfold difference may not sound all that much at the first
glance, the biological magnitude of these differences is
enormous, i.e. a tenfold different affinity roughly corre-
sponds to a 1,000-fold higher peptide concentration in
functional avidity assays (see Defining the TCR binding
and stimulatory potency of peptide MHC complexes).
Thus, T cell selection in the thymus strongly underlines the
ability of T cells to efficiently discriminate differences in
the affinity of interaction between pMHC and the TCR and
respond accordingly. More recent studies have defined the
TCR affinity where negative selection is initiated [31]. In
the presence of CD8 binding, TCRs at the negative selec-
tion threshold bind their pMHC antigens with a KD *6 lM
and have a half-life of *2 s. The mechanism for the
initiation of negative selection has been proposed to
involve a TCR/co-receptor zipper [32].
In contrast to thymic selection, peripheral T cell acti-
vation was thought to require stronger TCR stimulation
and high affinity pMHC and TCR interaction. This view
was mainly supported by the observation that following
an infection the bulk population of effector or memory T
cells responds with high functional avidity (see Defining
the TCR binding and stimulatory potency of peptide MHC
complexes) to their antigen [33]. The assumption that
strong signals are required for peripheral T cell activation
was challenged by observations that, even in the absence
of foreign antigen, meaning in the absence of pMHC that
strongly bind to the TCR, T cells slowly proliferate and
over time can obtain memory like phenotypes. This phe-
nomenon has been termed homeostatic proliferation (HP)
and plays a role in peripheral maintenance of T cells [34].
HP is thought to happen at all times, but it is most
prominent when cells are in a lymphopenic host. The
evidence that weak TCR pMCH interactions are the
driving force behind HP was obtained in mice that present
only a single pMHC that contains the very weak OT-1
APL R4. This monospecific pMHC situation was achieved
by using TAP-deficient mice which fail to present pep-
tides derived from intracellular proteins. R4 presentation
in these mice was selectively restored upon using a con-
struct that enables R4 translocation into the endoplasmic
reticulum independently of TAP. Despite the weak TCR
binding properties of R4 to the OT-1 TCR, this epitope
nonetheless restored the ability to induce homeostatic
OT-1 T cell proliferation [35]. As R4 also positively
selects OT-1 in FTOC systems [30], it was furthermore
concluded that both processes are driven by similar
pMHC affinities.
Interestingly, T cells that underwent HP showed typical
phenotypic features of memory T cells such as expressing
high levels of CD44 or being able to more rapidly secrete
IFN-c or granzymes and perforin in response to TCR
stimulation. In line with this, it was subsequently demon-
strated that T cells, which underwent strong HP, show
similar ability to protect mice from lethal pathogen chal-
lenges as conventional memory T cells [36]. This
observation lead to the introduction of the term HP mem-
ory T cell. Interestingly, one study even found that, among
the rare antigen-specific T cells found in the naı¨ve T cell
population, a fraction of these antigen-specific T cells show
an HP memory phenotype [37]. Taken together, all these
data indicate that even the weakest TCR ligand can in
principle support memory T cell differentiation. Moreover,
it also shows that peripheral T cells likely retain the ability
to respond to those ligands by which they were positively
selected in the thymus.








This is an elegant system for studying T cell
differentiation in the thymus [38]. Such
cultures are performed with thymi harvested
from day 15 embryos. These can be thymi
taken from normal mice, but they are often
obtained from TCR transgenic mice. For
studying the ability of different APL (see
Altered peptide ligands (APL)) to induce
positive and negative selection very often
OT-1 transgenic and TAP- or b2m-deficient
donor mice are used. Any of the two
deficiencies ensures that the thymus will
not present endogenous peptides to the OT-1
and therefore T cell development is blocked
at the double positive stage prior to positive
selection. Upon adding soluble synthetic
peptides (and b2m to b2m-deficient thymi),
one can create a thymus that only presents a
defined synthetic peptide. These cultures are
used to determine whether a specific peptide





Studies on how differences in the strength of
pMHC and TCR interaction impact T cell
responses are inevitably linked to TCR
transgenic T cells and so-called altered
peptide ligands. APL are ligands that differ
by at least one amino acid from the original
ligand against which a transgenic T cell was
raised, and these substitutions impact the
binding affinity of the corresponding pMHC
to the TCR of the transgenic T cell. In cases
of OT-1 and their natural H-2 Kb restricted
ligand, SIINFEKL, one can for instance
replace the amino acids at position 1 (S
against E) or at position 4 (N against R or G)
and thereby create ligands that only very










T cells translate a molecular event, the
binding of pMHC complexes to a TCR and
its coreceptor, into a cellular response. In
line with this, there are both bio-physical
and biological parameters that can be used
to describe how well the TCR or the whole
cell responds to pMHC. The bio-physical
parameters are TCR/pMHC affinity, on-and
off-rates, and half-life times of the complex,
all of which are terms commonly used to
describe kinetic aspects of monomeric
interactions between two molecules. These
parameters can for instance be measured by
surface plasmon resonance [39]. While these
parameters give the most precise assessment
of the ability of the TCR to bind to pMHC, it
requires substantial effort and the
availability of both soluble pMHC and
TCR to measure them. A more practical
but less precise assessment of the physical
strength of pMHC and TCR interaction is to
use soluble peptide MHC-tetrameric
molecules and to measure binding of those
molecules to the surface TCR of T cells. In
analogy to the biochemical term avidity,
which is normally used to describe the
strength of multimeric receptor ligand
interactions, these measurements are
usually referred to as pMHC and TCR
avidity [40, 41].
Besides the physical strength of pMHC and
TCR interaction, there are a number of other
factors that can influence the ability of a T
cell to respond to pMHC. Moreover, T cells
can differ in their ability to translate the
signals received though the TCR into a
cellular response [42, 43]. It is therefore also
important to determine the biological
activity of a given pMHC. This can be
done by testing the ability of a T cell to
respond to different amounts of pMHC
ligands [40]. This measure is usually
referred to as functional avidity (though it
is also often abbreviated as avidity) and it
can also be seen as a measure of antigen
sensitivity of a T cell [40]. Importantly,
functional avidity measurements correlate
well in most cases with the physical
parameters.
A broad range of pMHC TCR affinities support effector
and memory differentiation during an immune response
The naı¨ve T cell repertoire is enormously diverse and
contains T cells that respond to foreign antigen with a
range of high and low affinities. The population of antigen-
specific T cells that forms during an infection appears to be
only composed of high affinity T cells and this discrepancy
raised the question what happens to the low affinity T cells
during an infection?
Different observations indicate that even suboptimal
levels of TCR stimulation can support effector and memory
T cell differentiation. For instance, in autoimmune models
where high affinity T cells have been eliminated by thymic
or peripheral tolerance, lower affinity effector T cells can
be detected that respond to antigen stimulation [44, 45].
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Similarly, vaccines that contain so-called tumor-associated
antigens usually induce lower affinity effector and memory
T cells. Moreover, even T cells with mutation in the TCR
signaling apparatus, which results in less potent activation
(see below), can sometimes give rise to effector and
memory T cells.
The most direct way to address the question of how
differences in the level of TCR stimulation impact T cell
responses during an infection is to use pathogens that
encode APLs for TCR transgenic T cells (see Defining the
TCR binding and stimulatory potency of peptide MHC
complexes). Such has for instance been done using P14
TCR transgenic T cells and spontaneous mutants derived
from lymphocytic choriomeningitis virus (LCMV) that
contain APL for the P14 T cells. These studies showed that
a broader range of pMHC and TCR affinity induces the
activation of P14 cells [46], but it remained unclear why
low affinity T cells cannot be detected in a polyclonal
response after a pathogen infection. In a more recent study,
Listeria monocytogenes strains that stably express oval-
bumin containing APL for the OT-1 T cells were used [33].
Using this setup, it could be clearly demonstrated that very
low potency ligands support T cell differentiation. Those
even included ligands that failed to negatively select OT-1
thymocytes in FTOC systems—a notion that will be dis-
cussed in more detail below. Despite their striking affinity
differences, high or very low affinity ligands induced
similar initial T cell responses, i.e., in all cases, the cells
went at least through 7–9 divisions and this occurred at a
comparable pace with an estimated division time of 4–6 h.
Only after this initial period did low and high affinity
stimulated T cells begin to respond differently, in that more
strongly stimulated T cells terminally accumulated at much
larger numbers, proliferated longer, and began to decline in
numbers later than T cells stimulated by low affinity
ligands. All in all, these studies show a direct correlation
between the pMHC TCR affinity and the number of divi-
sions and extent of T cell accumulation. Most importantly,
even tiny differences in the functional avidity lead to sig-
nificantly different T cell numbers [33].
The different times spent in the expansion phase after
high and low affinity antigen stimulation is also the reason
why in a polyclonal repertoire the population of antigen-
specific T cells appears to be entirely composed of high
affinity T cells. High affinity T cells simply outnumber the
low affinity T cells so much that we normally fail to detect
them when analyzing the T cell response at the peak of
expansion or at any later time point. However, when
looking at polyclonal T cells at 4.5 days post-infection, low
affinity T cells can be detected [33].
Rather surprisingly, major phenotypic differences
between high and low affinity stimulated T cells were not
observed. They all showed a typical effector signature,
were CD44 high, CD62L low, expressed granzyme B,
INFc, and many also TNFa. Moreover, even very low
affinity primed T cells mounted a cytotoxic response [33]
and very low affinity pMHC TCR interaction support the
clearance of Listeria monocytogenes (D.Z. and M.J.B.,
unpublished observation). Finally, no matter what type of
TCR stimulation the T cell had received, they all become
memory T cells and those were equally competent in
mounting a secondary response. These observations led to
the conclusion that very low levels of TCR stimulation are
sufficient to fully differentiate T cells but fail to generate
large numbers of effector and memory T cells [33].
Nonetheless, if the conclusions drawn from experiments
using TCR transgenic OT-1 T cells are correct, then lower
affinity effector and subsequently lower affinity memory T
cells should be detectable after an infection. Indeed, using a
heterologous prime/challenge setup where a Lm-N4
infection (high affinity wild-type SIINFEKL ligand) is
followed by an Lm-V4 infections (low affinity APL
ligand), we could detect such cells. When mice are pri-
marily infected with Lm-N4, less than 20 % of the N4-
specific T cells cross-react with the V4 epitope. When mice
are first infected with Lm-N4 and later with Lm-V4, more
than 50 % of the cells in the secondary infection respond to
both peptides. The elevation in the numbers of N4/V4
cross-reactive T cells indicates that many of these cells are
derived from memory T cells generated during the earlier
Lm-N4 infection. The important detail in these experi-
ments is that the N4/V4 cross-reactive T cells strongly
react to V4 but only weakly to N4. Thus, the majority of
the cross-reactive T cells are descendents of memory T cell
clones that were primed by low affinity N4 stimulation
[47].
For OT-1 TCR transgenic T cells, a very large number
of APLs have been identified and well characterized in
terms of their affinity for the OT-1 TCR and their ability to
mediate positive or negative selection in FTOC systems.
The border between these two categories is marked by the
T4 APL which, depending on the amount of presented
peptide, can either support positive or negative selection.
Thus, APL with lower functional avidity than T4, i.e.
Q4H7, V4, E1, or G4, induce only positive selection, and
any stronger ligand, such as Q4R7, Q4, A2, or wild-type
SIINFEKL, induce negative selection [48]. In contrast to
their ability to stimulate positive but not negative selection
in FTOC, V4, Q4H7, and T4 induced the above-described
phenotypic and functionally complete differentiation of
effector and memory T cells. In a Listeria infection, only
the lowest affinity ligands such as E1 failed to expand
OT-1 (D.Z. and M.J.B., unpublished observations). These
data clearly indicate that there is a difference between the
thresholds for negative selection and induction of OT-1
proliferation in the periphery. These observations are also
TCR signaling requirements for activating T cells 1569
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well in line with reports showing that cells with low
functional avidity escape negative selection but can be
activated in the periphery and harbor the potential to cause
autoimmunity [44, 45].
Number of TCR and pMHC complexes (quantity)
needed for T cell activation
Following a pathogen challenge, type I and II interferons
strongly upregulate MHC expression on many types of
cells. While an infected cell will present virus-derived
proteins fragments, many of the surface MHC are even in
this situation loaded with peptides derived from self-pro-
teins [49]. Thus, during an infection, DC will present a
mixture of self- and viral peptides. An important aspect is
how many copies of a distinct pathogen-derived peptide are
presented by MHC molecules during an infection, and a
question related to that is how many are needed to activate
a naı¨ve T cell?
While it is still very difficult and often still impossible to
precisely determine the epitope density of a distinct pMHC,
a few examples have been provided where numbers of
specific pMHC on the cell surface could be elucidated. In
1996, a first study pointed out that even a single pMHC
might be sufficient for inducing effector activation [50].
However, the conclusions in this study were drawn without
direct proof that an APC presenting only a single specific
pMHC can activate T cells. Such proof was provided in a
later study where highly sensitive imaging techniques were
used to detect low numbers of fluorescently labeled MHC
bound peptides. With this approach, it was directly dem-
onstrated that 1–3 pMHC are sufficient for triggering
effector T cell functions and 10 pMHC for fully activating
T cells [51–53]. That different numbers of pMHC are
needed to induce different T cell functions is also sup-
ported by other circumstantial evidence. It is well known
that, when T cells are exposed to titrated doses of peptides,
higher concentrations of peptide are needed for inducing
proliferation and cytokine secretion whereby cytotoxicity
can be induced using slightly lower concentrations [54].
Despite the principal demonstration that a few pMHC can
induce T cell activation in vitro, it is not known whether
such low numbers are sufficient for T cell activation in
vivo.
Do self-pMHC contribute to T cell activation?
It is well established that peripheral T cells weakly interact
with self-pMHC complexes and that those weak engage-
ments provide a survival signal for naı¨ve peripheral T cells.
Considering that an antigen-presenting cell even during an
infection will present a large number of self-peptide MHC,
an interesting question is whether these contribute to T cell
activation.
In an early attempt to answer this question, RMA-S cells
were used which, unlike their parental cell line RMA, are
TAP-deficient and therefore largely lack surface MHC.
Both types of cells can be loaded with synthetic H-2Kb
binding peptidesm and the number of resulting pMHC can
be measured by the 16-D1.25 antibody [54]. Interestingly,
RMA-S and RMA cells that present similar numbers of
pMHC can stimulate OT-1 T cells equally well and irre-
spective of the presence or absence of self-pMHC [55]. The
same question was subsequently investigated using a very
sophisticated setup. Here, recombinant MHC molecules
were loaded either with a cognate peptide that efficiently
stimulates TCR transgenic T cells or with a self-peptide
that is weakly recognized by the same TCR. In this setup,
monomeric peptide MHC molecules failed to activate the
transgenic T cells while, as expected, dimeric peptide
MHC molecules carrying two cognate peptides efficiently
activated the T cells. Very surprisingly, even hetero-dimers
composed of the cognate and the self-peptide efficiently
stimulated the T cell response [56]. These studies clearly
contrast with the RMA work, but a possible explanation for
this discrepancy is that both RMA and RMA-S cells may
present such a large number of specific pMHC that, irre-
spective of the presence or absence of self-pMHC, there are
simply enough cognate pMHC on the surface to activate
the T cells. It should also be noted that RMA-S are not
completely free from self-pMHC and that they still present
some pMHC loaded with peptide despite the absence of
functional TAP molecules. In any case, the heterodimer
observations strongly suggest that self-pMHC augment T
cell activation. Other studies show a similar supporting
effect of self-pMHC [57, 58], and it has been observed that,
when T cells are deprived from pMHC contacts, they
become less sensitive to stimulation [59].
Signaling pathways in memory T cells
The difference in signaling efficiency between naı¨ve and
memory T cells could originate at multiple points along the
TCR-driven signaling pathways as discussed below and
shown in Fig. 1. Memory T cells are generated during or
following the primary response, and there have been
numerous studies which have examined the kind of TCR
signals that are required for generating T cell memory.
However, a second issue is to clarify whether fully devel-
oped memory T cells utilize distinct signaling pathways
compared to those used by naı¨ve T cells. Although these
two problems are not always discussed separately, some of
the work in this area is presented below.
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The difference in signaling efficiency between naı¨ve and
memory T cells could originate at multiple points along the
TCR-driven signaling pathways. Using mice with inducible
Lck expression, Tewari et al. [60] showed that unlike in a
primary response, Lck was dispensable for the induction of
a memory CD8 T cell response. The authors speculate that
the Ga11-dependent, phospholipase C-b-mediated pathway
may compensate for the absence of Lck expression as is the
case with TCR signaling driven by bacterial super antigens.
Another possibility is that memory T cells express more
phosphoproteins in their lipid rafts compared to their naı¨ve
counterparts, and this provides a primed state, which
compensates for the lack of Lck activity in LckOFF mice.
Given the fact that much of the Lck pool is CD8-associ-
ated, it is not surprising that memory CD8 T cells are also
less dependent on CD8 co-receptor function.
Using a novel approach, Au-Yeung et al. [61] engi-
neered a mutant ZAP-70 gene, whose gene product could
be inhibited by a small molecular weight inhibitor, 3-MB-
PP1. By combining the genetically modified mouse strain
and the inhibitor, the authors could block ZAP-70 kinase
activity during various points during an immune response.
In contrast to the results with Lck (see above), the acti-
vation of memory T cells requires ZAP-70 kinase activity.
One caveat is that given the inhibitor’s short half-life in
vivo, the inhibitor’s effect on memory T cells was assayed
ex vivo. Nevertheless, if ZAP-70 but not Lck kinase
activity is required to activate memory T cells, the impli-
cation is that ZAP-70 is activated by a kinase other than
Lck. Whether this is Fyn or whether ZAP-70 is activated by
an alternative mechanism is not yet known.
SLP-76 is an important phosphoprotein that nucleates
signaling complexes required for the propagation of TCR
signals [62]. Using mice, which can express mutations in
the SLP-76 gene in an inducible manner, Smith-Garvin
et al. [63] could show that the Y145F, and to a lesser extent
the Y112F/Y118F double mutation, dampened TCR sig-
nals and that this favors the development of memory T
cells at the expense of terminally differentiated effector
cell. This may reflect the normal development of T cell
memory, which begins following antigen clearance when T
cells no longer encounter antigen-bearing APCs. T cells
expressing mutant SLP-76 proteins may not be able to
respond to lower levels of antigen as well as wild-type T cells
and for this reason may enter the memory differentiation
program at an earlier point. Given the importance of the
transcription factor Tbet in driving effector T cell differen-
tiation, attenuating SLP-76 signaling may operate by
reducing Tbet expression through the SLP-76 ?
mTOR ? Tbet pathway or alternatively a SLP-76 ?
ITK ? Tbet pathway. Interestingly, CD8 T cell memory
can be generated from T cells expressing mutant SLP-76
even when the same cells are unable to express normal
amounts of inflammatory cytokines. A similar study also
showed that the persistence of memory T cells was inde-
pendent of SLP-76 [64].
Bushar et al. [65] examined the role of SLP-76 signaling
in establishing CD4 memory T cells. In contrast to its
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6 dependence on IL-2 / CD25 signaling (ref. 84)
Fig. 1 Differences between
naı¨ve and memory T cells
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negative role in the development of CD8 memory T cells,
SLP-76 has a positive function in the development of CD4
memory T cells. SLP-76 deficiency in memory CD4 T cells
inhibited expression of recall cytokines and decreased
memory T cell persistence in vivo. Furthermore, SLP-76
deficiency reduced the steady state homeostasis and
expansion of CD4 memory T cells despite the presence of
intact IL-7 signaling. These data argue that the survival of
CD4 memory T cells depends on TCR stimulation and
intact SLP-76-dependent signaling pathways. Why CD4
memory T cells are more dependent on TCR and SLP-76
signaling compared to their CD8 counterparts is not yet
clear.
Looking further downstream, D’Souza et al. [66]
examined the effects of ERK deficiency on CD8 T cell
activation, proliferation, and survival. While ERK-1 seems
dispensable, the absence of ERK-2 had serious conse-
quences for CD8 T cells. Surprisingly, ERK-2 deficiency
does not affect CD8 T cell proliferation but limits clonal
burst size by limiting T cell survival. This is likely medi-
ated by decreased Bcl-2 and Bcl-XL and increased Bim
expression. The observation that Bim deficiency rescues
this survival defect supports this idea. As ERK phosphor-
ylates the FoxO3 transcription factor leading to its
degradation and Bim transcription is dependent on FoxO3,
this is a potential mechanism of how ERK activity can
inhibit Bim expression and promote CD8 T cell survival
[66, 67]. A similar phenotype has been observed in PKC-h-
deficient [68] and RasGRP1-deficient [69] T cells (normal
proliferation but poor survival). As PKC-h and RasGRP1
activity each contributes to ERK activation, deficiency of
either of these upstream ERK activators may similarly lead
to increased Bim expression and decreased CD8 T cell
survival. It should be pointed out that these studies did not
directly examine memory responses, but rather survival of
T cells, during the primary response. It is likely that the
efficiency of T cell survival during the contraction phase of
the primary response affects the number of cells, which
enter the memory pool.
Arbour et al. [70] studied anti-viral responses in JNK1-
and JNK2-deficient mice and observed divergent roles for
these two related map kinases. Although both types of
knockout mice could clear LCMV infections, antigen-
specific CD8 T cells expanded poorly in JNK1-deficient
animals. This was due to an increase in apoptosis of the
expanding T cell population. Nevertheless, the surviving T
cells expressed IFN-c. Interestingly, memory responses to
LCMV were equivalent in JNK1-deficient and wild-type
mice. CD8 memory T cells may not require JNK1, and T
cells surviving the primary response were selected for
their JNK1 independence. In contrast, JNK2 knockout
mice displayed an increased expansion of antigen-specific
CD8 T cells compared to JNK2-sufficient animals. The
mechanism underlying these striking differences has not
yet been elucidated. Given that JNK isoforms are involved
in TCR and co-stimulatory signaling pathways, it has been
difficult to pin down where the JNK proteins function
during the anti-viral responses. One attractive candidate for
JNK1 is the co-stimulatory molecule, 4-1BB, since the
4-1BB ligand and JNK1 knockouts have similar pheno-
types. The authors suggest that JNK1 may be required for
transducing signals from the 4-1BB receptor.
Kersh et al. [71] studied a number of signaling com-
ponents in CD8 memory T cells and observed that, despite
an equivalent ability to phosphorylate CD3f and ZAP-70,
they more efficiently phosphorylate LAT, ERK, JNK, and
p38 compared to naı¨ve and effector T cells. They linked
these differences to the presence of more lipid rafts con-
taining increased amounts of asialo-GM1 and a higher
content of phosphor proteins, including LAT. As asialo-
GM1 contains less negatively charged sialic acid, it is
possible that this difference allows for the formation of
more tightly packed clusters of lipid rafts in CD8 memory
T cells. CD8 memory T cells also phosphorylated LAT
more efficiently upon antigen stimulation compared to their
naı¨ve and effector counterparts. The authors suggest that
these changes account for the rapid induction of TCR
signaling observed in CD8 memory T cells.
NFjB signaling is important in T cell responses, and its
role has been examined in the generation of T cell memory.
Members of the NFjB transcription factor family are kept
inactive by binding to members of the IjB family including
IjBa, IjBb, and IjBe. IKK1 and IKK2 are kinases, which
phosphorylate IjB proteins leading to their ubiquitination
and subsequent degradation by the 26S proteasome. This
releases the NFjB allowing its translocation to the nucleus
to fulfill its role as a transcription factor. Using a T cell-
specific deletional approach, Schmidt-Supprian et al. found
that IKK2 was not required for the survival of naı¨ve
peripheral T cells, but was essential for the generation of
CD4 memory and regulatory T cells [72, 73]. A similar
dependence on NFjB signaling for the generation of CD8
memory T cells was seen in mice expressing a dominant
negative form of IjBa [74].
Along this line, Teixeiro et al. [75] described a mutant
TCR, which supported primary CD8 T cell responses, but
failed to generate a memory response. The mutation was
located within the CART motif of the TCRb chain; this is a
highly conserved transmembrane sequence present within
all vertebrate B and T cell receptor genes. The mutant TCR
displays two obvious defects: it co-localizes poorly in the
synapse and it only weakly activates NFjB signaling. Given
the mutant receptor’s inability to be recruited to the syn-
apse, it is likely that the PKC-h ? Carma-1 ? Malt1 ?
Bcl-10 ? IKK2 pathway is poorly activated, leading to
inefficient and delayed NFjB activation. It is intriguing that
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the conserved IKK2-driven signaling pathway has rela-
tively little impact on primary responses, but is critical for
generating long-lived memory T lymphocytes.
mTOR has also been shown to have a pivotal role in the
development of CD8 T cell memory. Pearce et al. [76]
noticed that TRAF6-deficient T cells are unable to generate
a memory response. An analysis of TRAF6 knockout T
cells revealed that they were defective in activating AMP-
activated kinase and were altered in mitochondrial fatty
acid oxidation. Following these data, the authors treated
mice harboring TRAF6-deficient T cells with metformin or
rapamycin, which are known to affect cellular metabolism.
Treatment with either of these inhibitors was able to restore
the memory response from TRAF6-deficient T cells.
Independently, Araki et al. [77] found that rapamycin
increased the number of CD8 memory T cells in normal
mice, which was due to its inhibition of mTOR within the
mTORc1 complex. Using an RNAi knockdown approach,
these authors were able to show that mTORc1 regulates the
development of T cell memory. Both mTOR and AMPK
regulate cell growth by controlling how the T cell produces
energy. Following antigen stimulation, the T cell switches
from catabolic metabolism (oxidative phosphorylation via
fatty acid metabolism) to anabolic metabolism (via gly-
colysis) [78]. To generate memory T cells, mTOR and
AMPK are involved in switching back from anabolic to
catabolic metabolism. It is still not clear how changing the
mode of ATP production (via catabolic metabolism) results
in development of a memory phenotype. More work will
likely clarify the relationship between metabolism and the
establishment of T cell memory.
TCR signals have also been shown to synergize with
IL-2 receptor and CD28 to activate the PI3K-dependent
kinase, Akt. Although Akt has been traditionally linked
with the regulation of T cell metabolism [79], recent work
by Macintyre et al. [80] demonstrated normal glucose
uptake and survival by Akt-inhibited T cells. Instead, Akt-
mediated signals downstream from TCR and IL-2 receptor
appear to control effector T cell differentiation at the
expense of memory T cell generation. Microarray analysis
of gene expression in Akt-inhibited T cells revealed
increased expression of memory-associated genes includ-
ing IL-7R, CCR7, and CD62L while effector-associated
gene expression, including IFN-c, granzyme B, and per-
forin, were reduced. The authors went on to show that Akt-
mediated inhibition of FoxO3a-regulated gene expression
is an important factor driving effector T cell differentia-
tion. Although this work does not distinguish the
independent contribution of TCR to effector T cell
development, it supports a terminal differentiation model
where strong/sustained signals promote full effector dif-
ferentiation while weak/aborted signals promote memory T
cell generation.
It is not surprising that some of the signaling pathways
may be differently utilized in memory and effector T cells
since these cells have different physiological roles. Mem-
ory T cells have to survive for long periods of time in the
absence of cognate antigen stimulation, but must be able to
quickly develop full effector function upon re-exposure to
the priming antigen. The issue of how a naı¨ve T cell
develops into both effector and memory lineage T cells is a
fascinating problem, which likely has parallels to gene
expression programs in other differentiating systems. The
elucidation of these events is ongoing, but there are clearly
many unanswered questions surrounding this complex
immunological problem.
References
1. Kaech SM, Wherry EJ, Ahmed R (2002) Effector and memory
T-cell differentiation: implications for vaccine development. Nat
Rev Immunol 2:251–262
2. Williams MA, Bevan MJ (2007) Effector and memory CTL
differentiation. Annu Rev Immunol 25:171–192
3. Blattman JN, Antia R, Sourdive DJ, Wang X, Kaech SM, Murali-
Krishna K, Altman JD, Ahmed R (2002) Estimating the precursor
frequency of naive antigen-specific CD8 T cells. J Exp Med
195:657–664
4. Geiger R, Duhen T, Lanzavecchia A, Sallusto F (2009) Human
naive and memory CD4? T cell repertoires specific for naturally
processed antigens analyzed using libraries of amplified T cells.
J Exp Med 206:1525–1534
5. Moon JJ, Chu HH, Pepper M, McSorley SJ, Jameson SC, Kedl
RM, Jenkins MK (2007) Naive CD4(?) T cell frequency varies
for different epitopes and predicts repertoire diversity and
response magnitude. Immunity 27:203–213
6. Obar JJ, Khanna KM, Lefrancois L (2008) Endogenous naive
CD8? T cell precursor frequency regulates primary and memory
responses to infection. Immunity 28:859–869
7. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ,
Miller JD, Slansky J, Ahmed R (1998) Counting antigen-specific
CD8 T cells: a reevaluation of bystander activation during viral
infection. Immunity 8:177–187
8. Butz EA, Bevan MJ (1998) Massive expansion of antigen-spe-
cific CD8? T cells during an acute virus infection. Immunity
8:167–175
9. Miller JD, van der Most RG, Akondy RS, Glidewell JT, Albott S,
Masopust D, Murali-Krishna K, Mahar PL, Edupuganti S, Lalor
S, Germon S, Del Rio C, Mulligan MJ, Staprans SI, Altman JD,
Feinberg MB, Ahmed R (2008) Human effector and memory
CD8? T cell responses to smallpox and yellow fever vaccines.
Immunity 28:710–722
10. Mempel TR, Henrickson SE, Von Andrian UH (2004) T-cell
priming by dendritic cells in lymph nodes occurs in three distinct
phases. Nature 427:154–159
11. Bousso P, Robey E (2003) Dynamics of CD8? T cell priming by
dendritic cells in intact lymph nodes. Nat Immunol 4:579–585
12. van Stipdonk MJ, Lemmens EE, Schoenberger SP (2001) Naive
CTLs require a single brief period of antigenic stimulation for
clonal expansion and differentiation. Nat Immunol 2:423–429
13. Masopust D, Kaech SM, Wherry EJ, Ahmed R (2004) The role of
programming in memory T-cell development. Curr Opin Immu-
nol 16:217–225
TCR signaling requirements for activating T cells 1573
123
14. van Stipdonk MJ, Hardenberg G, Bijker MS, Lemmens EE, Droin
NM, Green DR, Schoenberger SP (2003) Dynamic programming
of CD8? T lymphocyte responses. Nat Immunol 4:361–365
15. Jelley-Gibbs DM, Brown DM, Dibble JP, Haynes L, Eaton SM,
Swain SL (2005) Unexpected prolonged presentation of influenza
antigens promotes CD4 T cell memory generation. J Exp Med
202:697–706
16. Turner DL, Cauley LS, Khanna KM, Lefrancois L (2007) Per-
sistent antigen presentation after acute vesicular stomatitis virus
infection. J Virol 81:2039–2046
17. Henrickson SE, Mempel TR, Mazo IB, Liu B, Artyomov MN,
Zheng H, Peixoto A, Flynn MP, Senman B, Junt T, Wong HC,
Chakraborty AK, von Andrian UH (2008) T cell sensing of
antigen dose governs interactive behavior with dendritic cells and
sets a threshold for T cell activation. Nat Immunol 9:282–291
18. Prlic M, Hernandez-Hoyos G, Bevan MJ (2006) Duration of the
initial TCR stimulus controls the magnitude but not functionality
of the CD8? T cell response. J Exp Med 203:2135–2143
19. Dolfi DV, Duttagupta PA, Boesteanu AC, Mueller YM, Oliai CH,
Borowski AB, Katsikis PD (2011) Dendritic cells and CD28
costimulation are required to sustain virus-specific CD8? T cell
responses during the effector phase in vivo. J Immunol
186:4599–4608
20. Khanna KM, McNamara JT, Lefrancois L (2007) In situ imaging
of the endogenous CD8 T cell response to infection. Science
318:116–120
21. Stock AT, Mueller SN, van Lint AL, Heath WR, Carbone FR
(2004) Cutting edge: prolonged antigen presentation after herpes
simplex virus-1 skin infection. J Immunol 173:2241–2244
22. Shaulov A, Murali-Krishna K (2008) CD8 T cell expansion and
memory differentiation are facilitated by simultaneous and sus-
tained exposure to antigenic and inflammatory milieu. J Immunol
180:1131–1138
23. McGill J, Van Rooijen N, Legge KL (2008) Protective influenza-
specific CD8 T cell responses require interactions with dendritic
cells in the lungs. J Exp Med 205:1635–1646
24. McGill J, Legge KL (2009) Cutting edge: contribution of lung-
resident T cell proliferation to the overall magnitude of the
antigen-specific CD8 T cell response in the lungs following
murine influenza virus infection. J Immunol 183:4177–4181
25. Obst R, van Santen HM, Mathis D, Benoist C (2005) Antigen
persistence is required throughout the expansion phase of a
CD4(?) T cell response. J Exp Med 201:1555–1565
26. Williams MA, Bevan MJ (2004) Shortening the infectious period
does not alter expansion of CD8 T cells but diminishes their
capacity to differentiate into memory cells. J Immunol
173:6694–6702
27. Badovinac VP, Haring JS, Harty JT (2007) Initial T cell receptor
transgenic cell precursor frequency dictates critical aspects of the
CD8(?) T cell response to infection. Immunity 26:827–841
28. Foulds KE, Shen H (2006) Clonal competition inhibits the pro-
liferation and differentiation of adoptively transferred TCR
transgenic CD4 T cells in response to infection. Journal of
immunology 176:3037–3043
29. Blair DA, Lefrancois L (2007) Increased competition for antigen
during priming negatively impacts the generation of memory
CD4 T cells. Proc Nat Acad Sci USA 104:15045–15050
30. Alam SM, Travers PJ, Wung JL, Nasholds W, Redpath S,
Jameson SC, Gascoigne NR (1996) T-cell-receptor affinity and
thymocyte positive selection. Nature 381:616–620
31. Naeher D, Daniels MA, Hausmann B, Guillaume P, Luescher I,
Palmer E (2007) A constant affinity threshold for T cell tolerance.
J Exp Med 204:2553–2559
32. Palmer E, Naeher D (2009) Affinity threshold for thymic selec-
tion through a T-cell receptor-co-receptor zipper. Nat Rev
Immunol 9:207–213
33. Zehn D, Lee SY, Bevan MJ (2009) Complete but curtailed T-cell
response to very low-affinity antigen. Nature 458:211–214
34. Goldrath AW, Bevan MJ (1999) Selecting and maintaining a
diverse T-cell repertoire. Nature 402:255–262
35. Goldrath AW, Bevan MJ (1999) Low-affinity ligands for the TCR
drive proliferation of mature CD8? T cells in lymphopenic hosts.
Immunity 11:183–190
36. Hamilton SE, Wolkers MC, Schoenberger SP, Jameson SC
(2006) The generation of protective memory-like CD8? T cells
during homeostatic proliferation requires CD4? T cells. Nat
Immunol 7:475–481
37. Haluszczak C, Akue AD, Hamilton SE, Johnson LD, Pujanauski
L, Teodorovic L, Jameson SC, Kedl RM (2009) The antigen-
specific CD8? T cell repertoire in unimmunized mice includes
memory phenotype cells bearing markers of homeostatic expan-
sion. J Exp Med 206:435–448
38. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ,
Carbone FR (1994) T cell receptor antagonist peptides induce
positive selection. Cell 76:17–27
39. Wu LC, Tuot DS, Lyons DS, Garcia KC, Davis MM (2002) Two-
step binding mechanism for T-cell receptor recognition of peptide
MHC. Nature 418:552–556
40. Stone JD, Chervin AS, Kranz DM (2009) T-cell receptor binding
affinities and kinetics: impact on T-cell activity and specificity.
Immunology 126:165–176
41. Wang XL, Altman JD (2003) Caveats in the design of MHC class
I tetramer/antigen-specific T lymphocytes dissociation assays.
J Immunol Methods 280:25–35
42. Fahmy TM, Bieler JG, Edidin M, Schneck JP (2001) Increased
TCR avidity after T cell activation: a mechanism for sensing low-
density antigen. Immunity 14:135–143
43. Slifka MK, Whitton JL (2001) Functional avidity maturation of
CD8(?) T cells without selection of higher affinity TCR. Nat
Immunol 2:711–717
44. von Herrath MG, Dockter J, Oldstone MB (1994) How virus
induces a rapid or slow onset insulin-dependent diabetes mellitus
in a transgenic model. Immunity 1:231–242
45. Zehn D, Bevan MJ (2006) T cells with low avidity for a tissue-
restricted antigen routinely evade central and peripheral tolerance
and cause autoimmunity. Immunity 25:261–270
46. Gronski MA, Boulter JM, Moskophidis D, Nguyen LT, Holmberg
K, Elford AR, Deenick EK, Kim HO, Penninger JM, Odermatt B,
Gallimore A, Gascoigne NR, Ohashi PS (2004) TCR affinity and
negative regulation limit autoimmunity. Nat Med 10:1234–1239
47. Zehn D, Turner MJ, Lefrancois L, Bevan MJ (2010) Lack of
original antigenic sin in recall CD8(?) T cell responses. Journal
of immunology 184:6320–6326
48. Daniels MA, Teixeiro E, Gill J, Hausmann B, Roubaty D,
Holmberg K, Werlen G, Hollander GA, Gascoigne NR, Palmer E
(2006) Thymic selection threshold defined by compartmentali-
zation of Ras/MAPK signalling. Nature 444:724–729
49. Yewdell JW, Reits E, Neefjes J (2003) Making sense of mass
destruction: quantitating MHC class I antigen presentation. Nat
Rev Immunol 3:952–961
50. Sykulev Y, Joo M, Vturina I, Tsomides TJ, Eisen HN (1996)
Evidence that a single peptide-MHC complex on a target cell can
elicit a cytolytic T cell response. Immunity 4:565–571
51. Purbhoo MA, Irvine DJ, Huppa JB, Davis MM (2004) T cell
killing does not require the formation of a stable mature immu-
nological synapse. Nat Immunol 5:524–530
52. Huppa JB, Davis MM (2003) T-cell-antigen recognition and the
immunological synapse. Nat Rev Immunol 3:973–983
53. Irvine DJ, Purbhoo MA, Krogsgaard M, Davis MM (2002) Direct
observation of ligand recognition by T cells. Nature 419:845–849
54. Porgador A, Yewdell JW, Deng Y, Bennink JR, Germain RN
(1997) Localization, quantitation, and in situ detection of specific
1574 D. Zehn et al.
123
peptide-MHC class I complexes using a monoclonal antibody.
Immunity 6:715–726
55. Sporri R, Reis e Sousa C. 2002. Self peptide/MHC class I com-
plexes have a negligible effect on the response of some CD8? T
cells to foreign antigen. Euro J Immunol 32: 3161-70
56. Krogsgaard M, Li QJ, Sumen C, Huppa JB, Huse M, Davis MM
(2005) Agonist/endogenous peptide-MHC heterodimers drive T
cell activation and sensitivity. Nature 434:238–243
57. Wulfing C, Sumen C, Sjaastad MD, Wu LC, Dustin ML, Davis
MM (2002) Costimulation and endogenous MHC ligands con-
tribute to T cell recognition. Nat Immunol 3:42–47
58. Lo WL, Felix NJ, Walters JJ, Rohrs H, Gross ML, Allen PM
(2009) An endogenous peptide positively selects and augments
the activation and survival of peripheral CD4? T cells. Nat
Immunol 10:1155–1161
59. Stefanova I, Dorfman JR, Germain RN (2002) Self-recognition
promotes the foreign antigen sensitivity of naive T lymphocytes.
Nature 420:429–434
60. Tewari K, Walent J, Svaren J, Zamoyska R, Suresh M (2006)
Differential requirement for Lck during primary and memory
CD8? T cell responses. Proc Natl Acad Sci USA 103:16388–
16393
61. Au-Yeung BB, Levin SE, Zhang C, Hsu LY, Cheng DA, Killeen
N, Shokat KM, Weiss A (2010) A genetically selective inhibitor
demonstrates a function for the kinase Zap70 in regulatory T cells
independent of its catalytic activity. Nat Immunol 11:1085–1092
62. Jordan MS, Singer AL, Koretzky GA (2003) Adaptors as central
mediators of signal transduction in immune cells. Nat Immunol
4:110–116
63. Smith-Garvin JE, Burns JC, Gohil M, Zou T, Kim JS, Maltzman
JS, Wherry EJ, Koretzky GA, Jordan MS (2010) T-cell receptor
signals direct the composition and function of the memory CD8?
T-cell pool. Blood 116:5548–5559
64. Wiehagen KR, Corbo E, Schmidt M, Shin H, Wherry EJ,
Maltzman JS (2010) Loss of tonic T-cell receptor signals alters
the generation but not the persistence of CD8? memory T cells.
Blood 116:5560–5570
65. Bushar ND, Corbo E, Schmidt M, Maltzman JS, Farber DL
(2010) Ablation of SLP-76 signaling after T cell priming gen-
erates memory CD4 T cells impaired in steady-state and
cytokine-driven homeostasis. Proc Natl Acad Sci USA
107:827–831
66. D’Souza WN, Chang CF, Fischer AM, Li M, Hedrick SM (2008)
The Erk2 MAPK regulates CD8 T cell proliferation and survival.
J Immunol 181:7617–7629
67. Hedrick SM (2009) The cunning little vixen: foxo and the cycle
of life and death. Nat Immunol 10:1057–1063
68. Barouch-Bentov R, Lemmens EE, Hu J, Janssen EM, Droin NM,
Song J, Schoenberger SP, Altman A (2005) Protein kinase
C-theta is an early survival factor required for differentiation of
effector CD8? T cells. J Immunol 175:5126–5134
69. Priatel JJ, Teh SJ, Dower NA, Stone JC, Teh HS (2002) RasGRP1
transduces low-grade TCR signals which are critical for T cell
development, homeostasis, and differentiation. Immunity 17:
617–627
70. Arbour N, Naniche D, Homann D, Davis RJ, Flavell RA, Old-
stone MB (2002) c-Jun NH(2)-terminal kinase (JNK)1 and JNK2
signaling pathways have divergent roles in CD8(?) T cell-med-
iated antiviral immunity. J. J Exp Med 195:801–810
71. Kersh EN, Kaech SM, Onami TM, Moran M, Wherry EJ, Miceli
MC, Ahmed R (2003) TCR signal transduction in antigen-specific
memory CD8 T cells. J Immunol 170:5455–5463
72. Schmidt-Supprian M, Tian J, Ji H, Terhorst C, Bhan AK, Grant
EP, Pasparakis M, Casola S, Coyle AJ, Rajewsky K (2004) I
kappa B kinase 2 deficiency in T cells leads to defects in priming,
B cell help, germinal center reactions, and homeostatic expan-
sion. J Immunol 173:1612–1619
73. Schmidt-Supprian M, Courtois G, Tian J, Coyle AJ, Israel A,
Rajewsky K, Pasparakis M (2003) Mature T cells depend on
signaling through the IKK complex. Immunity 19:377–389
74. Hettmann T, Opferman JT, Leiden JM, Ashton-Rickardt PG
(2003) A critical role for NF-kappaB transcription factors in the
development of CD8? memory-phenotype T cells. Immunol Lett
85:297–300
75. Teixeiro E, Daniels MA, Hamilton SE, Schrum AG, Bragado R,
Jameson SC, Palmer E (2009) Different T cell receptor signals
determine CD8? memory versus effector development. Science
323:502–505
76. Pearce EL, Walsh MC, Cejas PJ, Harms GM, Shen H, Wang LS,
Jones RG, Choi Y (2009) Enhancing CD8 T-cell memory by
modulating fatty acid metabolism. Nature 460:103–107
77. Araki K, Turner AP, Shaffer VO, Gangappa S, Keller SA,
Bachmann MF, Larsen CP, Ahmed R (2009) mTOR regulates
memory CD8 T-cell differentiation. Nature 460:108–112
78. Pearce EL (2010) Metabolism in T cell activation and differen-
tiation. Curr Opin Immunol 22:314–320
79. Juntilla MM, Koretzky GA (2008) Critical roles of the PI3K/Akt
signaling pathway in T cell development. Immunol Lett
116:104–110
80. Macintyre AN, Finlay D, Preston G, Sinclair LV, Waugh CM,
Tamas P, Feijoo C, Okkenhaug K, Cantrell DA (2011) Protein
Kinase B Controls Transcriptional Programs that Direct Cyto-
toxic T Cell Fate but Is Dispensable for T Cell Metabolism.
Immunity 34:224–236
TCR signaling requirements for activating T cells 1575
123
